"The U.S. health insurance market has consolidated substantially, and each of the three large [PBMs] -- that together control 75% of the market -- is integrated with a large medical insurer. Recent government actions reflect concerns with how these big PBMs conduct their business and closer scrutiny of their parent companies. Here's an overview of these recent government and legislative actions and the potential implications for drug pricing and plan sponsors."  MORE >>